CABALETTA BIO INC (CABA)       0.6501  +0.02 (+3.19%)

0.6501  +0.02 (+3.19%)

US12674W1099 - Common Stock - After market: 0.6311 -0.02 (-2.92%)

Buy % Consensus

Analysts have set a mean price target of 9.86. This target is 1416.69% above the current price.
CABA was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CABA.
In the previous month the buy percentage consensus was at a similar level.
CABA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 0.654.0410.719.8615.75 - 521.44% 1,547.44% 1,416.69% 2,322.70%

Up and Down Grades

Date Firm Action Rating
2022-09-14 Wells Fargo Maintains Overweight
2022-08-30 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-08-12 Chardan Capital Maintains Buy
2022-05-25 Mizuho Maintains Buy
2021-12-15 Morgan Stanley Maintains Overweight
2021-12-08 Wells Fargo Initiate Overweight
2021-06-30 Mizuho Initiate Buy
2021-03-17 HC Wainwright & Co. Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA